| Alexis Jayne Chambers, CRNA | |
|
727 Hospital Dr, Shelbyville, KY 40065-1660 | |
| (502) 647-4085 | |
| (502) 647-4098 |
| Full Name | Alexis Jayne Chambers |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 727 Hospital Dr, Shelbyville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700451903 | NPI | - | NPPES |
| 7100740190 | Medicaid | KY | |
| 300072057 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3016142 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Jewish Hospital - Shelbyville | Shelbyville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Louisville Physicians Inc | 3476725599 | 1102 |
| Anesthesiology Consultants Enterprises, Pllc | 9830268671 | 36 |
News Archive
Luminex Corporation announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.
A new study by researchers at Wake Forest Baptist Medical Center sheds light on what causes certain kidneys to do better than others after being transplanted, providing doctors with an easy way to screen for donor kidneys that have the best chance of survival.
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease.
Early results from a large Phase-III trial suggest that adding bevacizumab to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment.
› Verified 6 days ago
| Entity Name | Anesthesiology Consultants Enterprises, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427246198 PECOS PAC ID: 9830268671 Enrollment ID: O20080520000047 |
News Archive
Luminex Corporation announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.
A new study by researchers at Wake Forest Baptist Medical Center sheds light on what causes certain kidneys to do better than others after being transplanted, providing doctors with an easy way to screen for donor kidneys that have the best chance of survival.
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease.
Early results from a large Phase-III trial suggest that adding bevacizumab to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment.
› Verified 6 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
Luminex Corporation announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.
A new study by researchers at Wake Forest Baptist Medical Center sheds light on what causes certain kidneys to do better than others after being transplanted, providing doctors with an easy way to screen for donor kidneys that have the best chance of survival.
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease.
Early results from a large Phase-III trial suggest that adding bevacizumab to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexis Jayne Chambers, CRNA Po Box 909, Louisville, KY 40201-0909 Ph: (502) 647-4085 | Alexis Jayne Chambers, CRNA 727 Hospital Dr, Shelbyville, KY 40065-1660 Ph: (502) 647-4085 |
News Archive
Luminex Corporation announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.
A new study by researchers at Wake Forest Baptist Medical Center sheds light on what causes certain kidneys to do better than others after being transplanted, providing doctors with an easy way to screen for donor kidneys that have the best chance of survival.
Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease.
Early results from a large Phase-III trial suggest that adding bevacizumab to chemotherapy as a treatment for newly diagnosed ovarian cancer reduces the risk of disease progression during the first year of treatment.
› Verified 6 days ago
William D Smith Jr., CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Chelsea Elizabeth Dresner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Jerred Davis Mccarty, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Donald David Hart Ii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Rosalie Spreen Gray, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 | |
Sarah Michelle Sanders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 727 Hospital Dr, Shelbyville, KY 40065 Phone: 502-647-4085 Fax: 502-647-4098 |